Log in to save this analysis

Save This Analysis

What do these columns mean?
Shared genes
Curated genes linked to both diseases (disease_gdp). The line below it shows how many of those are "corroborated" -- backed by 2+ independent database sources combined across both diseases, not resting on a single source's say-so.
Similarity score
Jaccard-based: shared genes ÷ the union of both diseases' entire gene sets, with a small boost from users who bookmarked both diseases. Treats both diseases symmetrically.
Overlap coefficient
Shared genes ÷ the smaller disease's own total gene count. Complements the similarity score above for asymmetric pairs -- e.g. a rare disease almost entirely "contained" in a common disease's much larger gene set scores low on Jaccard but high here.
P-value / FDR q-value
Is this gene overlap more than chance? An upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pair (the q-value is the one that accounts for testing thousands of pairs at once -- prefer it over the raw p-value).
Shared cluster
Links to a multi-disease cluster (see Disease Clusters) if both diseases of this pair were independently grouped together by that separate analysis.
ⓘ Shows only pairs whose gene overlap is too large to be down to chance (FDR q-value below 0.05). These are the rows marked ✓ sig. in the table. ⓘ Shows only pairs where both diseases also belong to the same group on the Disease Clusters page. Two separate analyses agree they're related, so the link is stronger. These are the rows with a link in the Shared cluster column.
0 selected Clear
Disease A ⇵Disease B ⇵Shared genes ⇵Similarity score ⇵Overlap coefficient ⇵P-value ⇵FDR q-value ▼ Shared cluster
Hepatocellular carcinoma Urocanate hydratase deficiency
1 gene
Show details
1 of 1 corroborated by 2+ sources
UROC1(7)
0.002 1.000 4.21e-2 4.40e-2 ✓ sig. —
Hepatocellular carcinoma Uterine bilocularis
1 gene
Show details
1 of 1 corroborated by 2+ sources
HOXA13(2)
0.002 1.000 4.21e-2 4.40e-2 ✓ sig. —
Prostatic neoplasms radio-tartaglia syndrome
1 gene
Show details
1 of 1 corroborated by 2+ sources
SPEN(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
immunodeficiency 115 with autoinflammation Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
RNF31(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Intellectual developmental disorder seizures polymicrogyria Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
TCP1(4)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. Cluster 5 →
neurodevelopmental disorder with severe motor impairment and absent language Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
DHX30(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Essential pentosuria Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
DCXR(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Familial telangiectasia cancer syndrome Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
ATR(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Prostatic neoplasms spondyloepiphyseal dysplasia, kondo-fu type
1 gene
Show details
1 of 1 corroborated by 2+ sources
MBTPS1(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Prostatic neoplasms systemic lupus erythematosus, susceptibility to, 1
1 gene
Show details
1 of 1 corroborated by 2+ sources
TLR5(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
hearing loss, autosomal recessive 116 Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
CLDN9(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
TPP1(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
DNAJC3(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
17-beta-hydroxysteroid dehydrogenase deficiency Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
HSD17B3(4)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Absence of fingerprints-congenital milia syndrome Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
ADAM9-related retinopathy Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
ADAM9(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
developmental and epileptic encephalopathy, 55 Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
PIGP(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Diffuse cerebral and cerebellar atrophy–intractable seizures–progressive microcephaly syndrome Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
QARS1(5)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Dimauro disease Prostatic neoplasms
1 gene
Show details
PGAM2(1)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Desanto-shinawi syndrome Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
WAC(6)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
leukodystrophy, hypomyelinating, 18 Prostatic neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
DEGS1(2)
0.002 1.000 4.07e-2 4.26e-2 ✓ sig. —
Intestinal vascular insufficiency Nonalcoholic fatty liver disease
1 gene
Show details
NEDD9(1)
0.003 0.500 4.06e-2 4.25e-2 ✓ sig. —
Nonalcoholic fatty liver disease Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome
1 gene
Show details
1 of 1 corroborated by 2+ sources
TRMT10A(3)
0.003 0.500 4.06e-2 4.25e-2 ✓ sig. —
Atelis syndrome Nonalcoholic fatty liver disease
1 gene
Show details
1 of 1 corroborated by 2+ sources
SLF2(4)
0.003 0.500 4.06e-2 4.25e-2 ✓ sig. —
Hyperprolinemia Nonalcoholic fatty liver disease
1 gene
Show details
1 of 1 corroborated by 2+ sources
ALDH4A1(7)
0.003 0.500 4.06e-2 4.25e-2 ✓ sig. —

Showing 25 of 20813 pairs, sorted by significance (descending). Click a column header to sort.